Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432)
2024 · Signal Transduction and Targeted Therapy · 15 citations
https://doi.org/10.1038/s41392-024-02060-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
86
Papers
710
Citations
16
h-index
25
i10-index
Bo Jia is an academic researcher from Nanjing Agricultural University. The author has contributed to research in topics: Semiconductor Quantum Structures and Devices & Advanced Fiber Optic Sensors & Advanced Semiconductor Detectors and Materials. The author has an h-index of 16, co-authored 74 publications.
ORCID: 0000-0002-0001-3851https://doi.org/10.1038/s41392-024-02060-3
https://doi.org/10.1186/s40807-025-00195-7
https://doi.org/10.1016/j.aqrep.2025.103083
Click to start Chat